Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Alternative splicing of mRNA precursors is a nearly ubiquitous and extremely flexible point of
gene control in humans. It provides cells with the opportunity to create protein isoforms of …
gene control in humans. It provides cells with the opportunity to create protein isoforms of …
Aberrant RNA splicing in cancer and drug resistance
BD Wang, NH Lee - Cancers, 2018 - mdpi.com
More than 95% of the 20,000 to 25,000 transcribed human genes undergo alternative RNA
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …
splicing, which increases the diversity of the proteome. Isoforms derived from the same gene …
A targeted proteomics–based pipeline for verification of biomarkers in plasma
JR Whiteaker, C Lin, J Kennedy, L Hou, M Trute… - Nature …, 2011 - nature.com
High-throughput technologies can now identify hundreds of candidate protein biomarkers for
any disease with relative ease. However, because there are no assays for the majority of …
any disease with relative ease. However, because there are no assays for the majority of …
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
S Calabretta, P Bielli, I Passacantilli, E Pilozzi… - Oncogene, 2016 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and incurable disease. Poor
prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the …
prognosis is due to multiple reasons, including acquisition of resistance to gemcitabine, the …
Персонализированная медицина: современное состояние и перспективы
ИИ Дедов, АН Тюльпаков, ВП Чехонин… - Вестник Российской …, 2012 - cyberleninka.ru
В обзоре описаны основные тенденции и направления персонализированной
медицины. Они включают предсказание на основе геномных данных вероятности …
медицины. Они включают предсказание на основе геномных данных вероятности …
The impact of biomarkers in pancreatic ductal adenocarcinoma on diagnosis, surveillance and therapy
N Sturm, TJ Ettrich, L Perkhofer - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma is a leading cause of cancer death
worldwide. Due to the frequently late diagnosis, early metastasis and high therapy …
worldwide. Due to the frequently late diagnosis, early metastasis and high therapy …
An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …
Proteogenomics
The ability to sequence DNA rapidly, inexpensively and in a high‐throughput fashion
provides a unique opportunity to sequence whole genomes of a large number of species …
provides a unique opportunity to sequence whole genomes of a large number of species …
A roadmap toward the definition of actionable tumor-specific antigens
R Minati, C Perreault, P Thibault - Frontiers in Immunology, 2020 - frontiersin.org
The search for tumor-specific antigens (TSAs) has considerably accelerated during the past
decade due to the improvement of proteogenomic detection methods. This provides new …
decade due to the improvement of proteogenomic detection methods. This provides new …
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators
VN Uversky - Frontiers in Molecular Biosciences, 2014 - frontiersin.org
Biologically active proteins without stable tertiary structure are common in all known
proteomes. Functions of these intrinsically disordered proteins (IDPs) are typically related to …
proteomes. Functions of these intrinsically disordered proteins (IDPs) are typically related to …